Abstract:Amycolatopsis sp. strain TNS106 harbors a ristomycin-biosynthetic gene cluster (asr) in its genome and produces ristomycin A. Deletion of the sole cluster-situated StrR family regulatory gene, asrR, abolished ristomycin A production and the transcription of the asr genes orf5 to orf39. The ristomycin A fermentation titer in Amycolatopsis sp. strain TNS106 was dramatically improved by overexpression of asrR and a heterologous StrR family regulatory gene, bbr, from the balhimycin-biosynthetic gene cluster (BGC) utilizing strong promoters and multiple gene copies. Ristomycin A production was improved by approximately 60-fold, resulting in a fermentation titer of 4.01 g/liter in flask culture, in one of the engineered strains. Overexpression of AsrR and Bbr upregulated transcription of tested asr biosynthetic genes, indicating that these asr genes were positively regulated by AsrR and Bbr. However, only the promoter region of the asrR operon and the intergenic region upstream of orf12 were bound by AsrR and Bbr in gel retardation assays, suggesting that AsrR and Bbr directly regulated the asrR operon and probably orf12 to orf14 but no other asr biosynthetic genes. Further assays with synthetic short probes showed that AsrR and Bbr specifically bound not only probes containing the canonical inverted repeats but also a probe with only one 7-bp element of the inverted repeats in its native context. AsrR and Bbr have an N-terminal ParB-like domain and a central winged helix-turn-helix DNA-binding domain. Site-directed mutations indicated that the N-terminal ParB-like domain was involved in activation of ristomycin A biosynthesis and did not affect the DNA-binding activity of AsrR and Bbr. IMPORTANCE This study showed that overexpression of either a native StrR family regulator (AsrR) or a heterologous StrR family regulator (Bbr) dramatically improved ristomycin A production by increasing the transcription of biosynthetic genes directly or indirectly. The conserved ParB-like domain of AsrR and Bbr was demonstrated to be involved in the regulation of asr BGC expression. These findings provide new insights into the mechanism of StrR family regulators in the regulation of glycopeptide antibiotic biosynthesis. Furthermore, the regulator overexpression plasmids constructed in this study could serve as valuable tools for strain improvement and genome mining for new glycopeptide antibiotics. In addition, ristomycin A is a type III glycopeptide antibiotic clinically used as a diagnostic reagent due to its side effects. The overproduction strains engineered in this study are ideal materials for industrial production of ristomycin A.

Identification of a gene from Streptomyces rimosus M527 negatively affecting rimocidin biosynthesis and morphological differentiation

Identification of RimR2 As a Positive Pathway-Specific Regulator of Rimocidin Biosynthesis in Streptomyces Rimosus M527.

Transposon-based Identification of Genes Involved in the Rimocidin Biosynthesis in Streptomyces Rimosus M527.

Study on a Two-Component Signal Transduction System RimA1A2 That Negatively Regulates Oxytetracycline Biosynthesis in Streptomyces Rimosus M4018

Sequential Improvement of Rimocidin Production in Streptomyces Rimosus M527 by Introduction of Cumulative Drug-Resistance Mutations

Improvement of Rimocidin Production in Streptomyces Rimosus M527 by Reporter-Guided Mutation Selection.

Improvement of Rimocidin Biosynthesis by Increasing Supply of Precursor Malonyl-CoA via Over-expression of Acetyl-CoA Carboxylase in Streptomyces rimosus M527

Identification of A Gene Negatively Affecting Antibiotic Production and Morphological Differentiation in Streptomyces Coelicolor A3(2)

RS24090, a TetR Family Transcriptional Repressor, Negatively Affects the Rimocidin Biosynthesis in Streptomyces Rimosus M527

Role of Nsda in Negative Regulation of Antibiotic Production and Morphological Differentiation in Streptomyces Bingchengensis

Molecular Mechanism of Mureidomycin Biosynthesis Activated by Introduction of an Exogenous Regulatory Gene Ssaa into Streptomyces Roseosporus

Effects of Addition of Elicitors on Rimocidin Biosynthesis in Streptomyces Rimosus M527

Identification of Mur34 as the novel negative regulator responsible for the biosynthesis of muraymycin in Streptomyces sp. NRRL30471.

Protein X0P338, a GntR-type Pleiotropic Regulator for Morphological Differentiation and Secondary Metabolites Production in Streptomyces Diastatochromogenes 1628

[Activation of Silent Antibiotic Synthesis in Streptomyces Lividans by Disruption of a Negative Regulator Nsda, a Gene Conserved in Streptomyces].

Developmental regulator RamR<sub>sl</sub> controls both morphological development and lincomycin biosynthesis in <i>Streptomyces lincolnensis</i>

Identification of Novel Mureidomycin Analogues Via Rational Activation of a Cryptic Gene Cluster in Streptomyces Roseosporus NRRL 15998.

Characterization of rrdA, a TetR family protein gene involved in the regulation of secondary metabolism in Streptomyces coelicolor.

Deletion of the signalling molecule synthase ScbA has pleiotropic effects on secondary metabolite biosynthesis, morphological differentiation and primary metabolism in Streptomyces coelicolor A3(2)

Transcriptional Regulator DasR Represses Daptomycin Production Through Both Direct and Cascade Mechanisms in Streptomyces Roseosporus

Enhancing Ristomycin A Production by Overexpression of ParB-Like StrR Family Regulators Controlling the Biosynthesis Genes